Skip to main content
. Author manuscript; available in PMC: 2024 Nov 14.
Published in final edited form as: Gut. 2024 Nov 11;73(12):e33. doi: 10.1136/gutjnl-2023-331687

Table 1:

Demographics and Incidence of ESCC in 3 Major African Cancer Registries between 2013 and 2017

Combined Nairobi, Kenya Eastern Cape, South Africa Kyadondo, Uganda
Number of cases 1022 384 340 298
Females, n (%) 482 (47.2%) 170 (44.3%) 196 (57.6%) 116 (38.9%)
Age group, n (%) - - - -
0 – 14 <5*** 0 (0%) <5*** 0 (0%)
15–29 21 (2.1%) 9 (2.3%) 9 (2.6%) <5***
30–44 104 (10.2%) 51 (13.3%) 16 (4.7%) 37 (12.4%)
45–59 372 (36.4%) 132 (34.4%) 110 (32.4%) 130 (43.6%)
60–74 375 (36.7%) 142 (37.0%) 141 (41.5%) 92 (30.9%)
75=> 149 (14.6%) 50 (13.0%) 63 (18.5%) 36 (12.1%)
Early Onset, n (%) 126 (12.3%) 60 (15.6%) 26 (7.6%) 40 (13.4%)
Cumulative Lifetime Incidence (per 100,000 person-years) * 1,508 1,560 1,805 1343
Cumulative Early Onset Incidence (per 100,000 person-years) * 33 27 82 33
Early Onset Proportion of Cumulative Incidence ** 2.2% 1.7% 4.5% 2.4%
*

The cumulative incidence is the sum of the age-specific incidence over each year of age from birth to a defined upper age limit.

**

The early onset disease proportion of cumulative incidence = cumulative incidence of early onset / cumulative lifetime incidence x 100

***

Unreported, cells where the number of cases ranged from 1 to 4 were represented as <5 to ensure privacy.